Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Hyperplasia 1

Interventions

Radiotherapy, Intensity-Modulated 3 Cisplatin 3 pembrolizumab 2 Metformin 2 Laparoscopy 2 Gemcitabine 2 Capecitabine 2 tremelimumab 1 sintilimab 1 nabiximols 1 lenvatinib 1 enzalutamide 1 durvalumab 1 capivasertib 1 avelumab 1 atezolizumab 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abiraterone 1 Zoledronic Acid 1 Trastuzumab 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Rituximab 1 Rehabilitation 1 Radiotherapy, Conformal 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Radiation 1 Rabeprazole 1 Proton Pump Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER_GOV × Levonorgestrel × Clear all

NCT01686126 2024-08-28

feMMe

Queensland Centre for Gynaecological Cancer

Phase 2 Active not recruiting

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡